Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of statin therapy on monocyte function in the metabolic syndrome
2006-000873-32Phase 4Terminated
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of atorvastatin in cardiometabolic risk (CMR), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Chemotactic response of extracted monocytes. Started Apr 2006; status: terminated.
02
Drugs
atorvastatin
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on 2006-000873-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000873-32.